bioMerieux's total assets for Q4 2024 were €5.77B, an increase of 8.48% from the previous quarter. GB:0RUG total liabilities were €1.56B for the fiscal quarter, a 8.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.